LEADER 03575nam  2200649 a 450 
001 9910806162503321
005 20240516065051.0
010   $a1-280-78407-5
010   $a9786613694461
010   $a0-470-72073-5
010   $a0-470-71842-0
035   $a(CKB)1000000000688145
035   $a(EBL)703912
035   $a(OCoLC)797918492
035   $a(SSID)ssj0000715489
035   $a(PQKBManifestationID)11435131
035   $a(PQKBTitleCode)TC0000715489
035   $a(PQKBWorkID)10701713
035   $a(PQKB)11341815
035   $a(MiAaPQ)EBC703912
035   $a(Au-PeEL)EBL703912
035   $a(CaPaEBR)ebr10575664
035   $a(CaONFJC)MIL369446
035   $a(EXLCZ)991000000000688145
100   $a19831122d1982      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aSubstance P in the nervous system
205   $a1st ed.
210   $aLondon $cPitman ;$aSummit, N.J., USA $cDistributed in North America by Ciba Pharmaceutical Co., Medical Education Administration$d1982
215   $a1 online resource (362 p.)
225 1 $aCiba Foundation symposium ;$v91
300   $a"Editors: Ruth Porter (organizer) and Maeve O'Connor"--P. v.
311   $a0-470-66408-8 
311   $a0-272-79655-7 
320   $aIncludes bibliographical references and indexes.
327   $aSubstance P in the nervous system; Contents; Introduction; Chemical neurotransmission-yesterday and today; Role of substance P as a sensory transmitter in spinal cord and sympathetic ganglia; Discussion; Substance P in peripheral sensory processes; Discussion; Localization of substance P in neuronal pathways; Discussion; Distribution of substance P in brain and periphery and its possible role as a co-transmitter; Discussion; Regulation of substance P expression and metabolism in vivo and in vitro; Discussion; GENERAL DISCUSSION; Coexistence of transmitters
327   $aSubstance P in nerve tissue in the gut Discussion; Biosynthesis, axonal transport and turnover of neuronal substance P; Discussion; Enzymic inactivation of substance P in the central nervous system; Discussion; Substance P receptors in the nervous system and possible receptor subtypes; Discussion; Relation of substance P to pain transmission: neurophysiological evidence; Discussion; Substance P in nociceptive sensory neurons; Discussion; If substance P fails to fulfil the criteria as a neurotransmitter in somatosensory afferents, what might be its function?; Discussion
327   $aModulation of cholinergic transmission by substance PDiscussion; The striatonigral substance P pathway and dopaminergic mechanisms; Discussion; Relation of substance P to stress and catecholamine metabolism; Discussion; Behavioural effects of substance P through dopaminergic pathways in the brain; Discussion; FINAL GENERAL DISCUSSION; Substance P antagonists; tumour cell lines and substance P; substance P and other tachykinins; substance P and clinical pain syndromes; substance P and neuronal systems; Index of contributors; Subject index
410  0$aCiba Foundation symposium ;$v91.
606   $aSubstance P$vCongresses
606   $aNeurology$vCongresses
615  0$aSubstance P
615  0$aNeurology
676   $a599/.0188
701   $aPorter$b Ruth$064811
701   $aO'Connor$b Maeve$0284912
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910806162503321
996   $aSubstance P in the nervous system$91963079
997   $aUNINA